Antidote Labeling via AI Clustering Models

The patent segments the complex data analysis process into two distinct machine learning models: an unsupervised learning model that processes user input data and generates probing elements, and a supervised learning model that maps these probing elements to antidote labels. This segmentation allows each model to specialize in specific tasks, improving overall accuracy while managing complexity through modular architecture.

The patent introduces probing elements as intermediary representations between user input data and antidote labels. These probing elements serve as a bridge that transforms complex user inputs into a standardized format that the supervised learning model can effectively process, thereby improving the accuracy of antidote selection without requiring the final model to directly handle all raw input complexities.

The patent divides the antidote selection process into two specialized models with distinct functions: the unsupervised learning model handles exploratory data analysis and feature generation, while the supervised learning model handles precise classification and prediction. This functional segmentation allows each model to be optimized for its specific task, improving detail and accuracy without requiring a single overly complex model.

The supervised learning model is designed to be universal by training on multiple probing elements generated from various types of user input data. This multi-functional approach allows the same model to handle diverse input scenarios (different symptoms, patient histories, and data formats) while maintaining high precision in antidote selection, reducing the need for separate specialized models for each input type.